GTEx AdiposeTissue 20-29 vs 30-39 Up (Gene Set)

Analyze

Playbook Workflow Builder
Playbook Workflow Builder: Gene Set Enrichment

Perform Gene Set Enrichment with this gene set against Common Fund program's gene sets, identifying significant overlaps using a pre-built PWB workflow. Run the workflow with GTEx AdiposeTissue 20-29 vs 30-39 Up.

GeneSetCart
GeneSetCart

GeneSetCart helps you to fetch gene sets from various data sources, augment, combine with set operations, visualize and analyze these gene sets in a single session. Start a new session with GTEx AdiposeTissue 20-29 vs 30-39 Up.

CFDE-GSE
CFDE Gene Set Enrichment (GSE)

CFDE-GSE illuminates connections between the input gene set and various CF gene sets that overlap with the queried gene set. Query CFDE-GSE with GTEx AdiposeTissue 20-29 vs 30-39 Up.

Playbook Workflow Builder
Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with GTEx AdiposeTissue 20-29 vs 30-39 Up.

Results found

Linked to

 

Label

Description

 

Gene

family with sequence similarity 106 member A

Gene

POU class 3 homeobox 3

Gene

double homeobox A pseudogene 8

Gene

long intergenic non-protein coding RNA 1291

Gene

uncharacterized LOC339260

Gene

MIR3142 host gene

Gene

embryonic stem cell related

Gene

long intergenic non-protein coding RNA 865

Gene

uncharacterized LOC100129434

Gene

glutamine insufficiency regulator of glutaminase lncRNA

  • Gene

    family with sequence similarity 106 member A


  • Gene

    POU class 3 homeobox 3


  • Gene

    double homeobox A pseudogene 8


  • Gene

    long intergenic non-protein coding RNA 1291


  • Gene

    uncharacterized LOC339260



  • Gene

    embryonic stem cell related


  • Gene

    long intergenic non-protein coding RNA 865


  • Gene

    uncharacterized LOC100129434


  • Gene

    glutamine insufficiency regulator of glutaminase lncRNA

  • DISPLAY PER PAGE
    This repository is under review for potential modification in compliance with Administration directives.